צמיחת מכירות ב-12 חודשים נגררים: Pharming Corp (PHAR)

How are rare genetic pathologies treated? Pharming Group N.V. implements advanced recombinant proteins for the therapy of complex diagnoses. The annual sales revenue dynamics over four quarters demonstrate the current trend, where 6.60 is the current level of the indicator. Pharming Group N.V. relies on external CMOs for drug filling, while a steady stream from orphan drugs guarantees liquidity and the development of research.
פילוחי נתונים אנליטיים מרוכזים עבור Pharming Group NV (PHAR)

The revenue dynamics of Pharming Group N.V. (PHAR) on this chart reflect the effectiveness of implementing a strategy dependent on CMO plants through long-term contracts. The relative change in rolling year revenue compared to the same period last year measures the turnover growth rate over the last 12 months, allowing investors to distinguish a sustainable market trend from short-term fluctuations and recognize the risks of share price overheating in a timely manner.